Journal of Clinical Endocrinology & Metabolism, Vol 77, 375-381, Copyright © 1993 by Endocrine Society

ARTICLES

Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate

M Krieg, R Nass and S Tunn
Institute of Clinical Chemistry and Laboratory Medicine, University Clinic Bergmannsheil, Bochum, Germany.

It is widely believed that benign prostatic hyperplasia (BPH) is associated with aging. Thus, the question arises whether or not a correlation exists between the well known prostatic androgen and estrogen accumulation and aging. To address this question, we measured 5 alpha-dihydrotestosterone (DHT), testosterone, estradiol, and estrone in epithelium and stroma of six normal (NPR) and 19 BPH and correlated the values with the age of the donors (26-87 yr). The mean DHT level in NPR epithelium was significantly higher than in NPR stroma, and also significantly higher than in epithelium and stroma of BPH. The epithelial DHT level of NPR and BPH decreased with age, the correlation being statistically significant. The stromal DHT level of NPR and BPH showed no correlation with age. Concerning testosterone, generally rather low values were found which showed no correlation with age. The mean levels of estradiol and estrone were significantly higher in BPH stroma as compared to BPH epithelium as well as to NPR epithelium and stroma. In NPR, the mean levels of estradiol and estrone were significantly higher in epithelium than stroma. In NPR and BPH, the stromal estradiol and estrone levels increased significantly with age. In epithelium such a correlation between the estrogen levels and age was not found. Our results indicate that the prostatic accumulation of DHT, estradiol, and estrone is in part intimately correlated with aging, leading with increasing age to a dramatic increase of the estrogen/androgen ratio particularly in stroma of BPH.

This article has been cited by other articles:

				M. Wald, M. Miner, and A. D. Seftel State of the Art Reviews: Male Menopause: Fact or Fiction? American Journal of Lifestyle Medicine, April 1, 2008; 2(2): 132 - 141. [Abstract] [PDF]

				K. T Gray, J. L Short, E. R Simpson, and S. Ventura The effects of targeted deletion of the aromatase enzyme on prostatic contractile responses to noradrenaline in mice J. Endocrinol., December 1, 2007; 195(3): 495 - 502. [Abstract] [Full Text] [PDF]

				Q. Wu, Y. Zhou, L. Chen, J. Shi, C.-Y. Wang, L. Miao, H. Klocker, I. Park, C. Lee, and J. Zhang Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2 J. Endocrinol., October 1, 2007; 195(1): 89 - 94. [Abstract] [Full Text] [PDF]

				E. A. Mostaghel, S. T. Page, D. W. Lin, L. Fazli, I. M. Coleman, L. D. True, B. Knudsen, D. L. Hess, C. C. Nelson, A. M. Matsumoto, et al. Intraprostatic Androgens and Androgen-Regulated Gene Expression Persist after Testosterone Suppression: Therapeutic Implications for Castration-Resistant Prostate Cancer Cancer Res., May 15, 2007; 67(10): 5033 - 5041. [Abstract] [Full Text] [PDF]

				S. J. McPherson, S. J. Ellem, E. R. Simpson, V. Patchev, K.-H. Fritzemeier, and G. P. Risbridger Essential Role for Estrogen Receptor {beta} in Stromal-Epithelial Regulation of Prostatic Hyperplasia Endocrinology, February 1, 2007; 148(2): 566 - 574. [Abstract] [Full Text] [PDF]

				S. T. Page, D. W. Lin, E. A. Mostaghel, D. L. Hess, L. D. True, J. K. Amory, P. S. Nelson, A. M. Matsumoto, and W. J. Bremner Persistent Intraprostatic Androgen Concentrations after Medical Castration in Healthy Men J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3850 - 3856. [Abstract] [Full Text] [PDF]

				J. J. Bianco, S. J. McPherson, H. Wang, G. S. Prins, and G. P. Risbridger Transient Neonatal Estrogen Exposure to Estrogen-Deficient Mice (Aromatase Knockout) Reduces Prostate Weight and Induces Inflammation in Late Life Am. J. Pathol., June 1, 2006; 168(6): 1869 - 1878. [Abstract] [Full Text] [PDF]

				Y. Tanaka, M. Sasaki, H. Shiina, T. Tokizane, M. Deguchi, H. Hirata, Y. Hinoda, N. Okayama, Y. Suehiro, S. Urakami, et al. Catechol-O-methyltransferase Gene Polymorphisms in Benign Prostatic Hyperplasia and Sporadic Prostate Cancer. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 238 - 244. [Abstract] [Full Text] [PDF]

				J. M. Kaufman and A. Vermeulen The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications Endocr. Rev., October 1, 2005; 26(6): 833 - 876. [Abstract] [Full Text] [PDF]

				E. L. Rhoden and A. Morgentaler Risks of Testosterone-Replacement Therapy and Recommendations for Monitoring N. Engl. J. Med., January 29, 2004; 350(5): 482 - 492. [Full Text] [PDF]

				M. A. Joseph, S. D. Harlow, J. T. Wei, A. V. Sarma, R. L. Dunn, J. M. G. Taylor, S. A. James, K. A. Cooney, K. M. Doerr, J. E. Montie, et al. Risk Factors for Lower Urinary Tract Symptoms in a Population-based Sample of African-American Men Am. J. Epidemiol., May 15, 2003; 157(10): 906 - 914. [Abstract] [Full Text] [PDF]

				C. A. Heinlein and C. Chang Androgen Receptor (AR) Coregulators: An Overview Endocr. Rev., April 1, 2002; 23(2): 175 - 200. [Abstract] [Full Text] [PDF]

				A. M. Matsumoto Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99. [Full Text]

				M. E. Taplin and S.-M. Ho The Endocrinology of Prostate Cancer J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3467 - 3477. [Full Text] [PDF]

				M. C. Bosland Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 39 - 66. [Abstract] [Full Text] [PDF]

				R. Palusinski, W. Barud, T. O'Gara, K. Ullis, T. N. Ziegenfuss, R. Cohen, W. D. Brink, W. J. Roberts, D. S. King, R. L. Sharp, et al. Effects of Androstenedione in Young Men JAMA, February 9, 2000; 283(6): 741 - 743. [Full Text] [PDF]

				M. Marcelli and G. R. Cunningham Hormonal Signaling in Prostatic Hyperplasia and Neoplasia J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3463 - 3468. [Full Text] [PDF]

				C. Wang, A. Iranmanesh, N. Berman, V. McDonald, B. Steiner, F. Ziel, S. M. Faulkner, R. E. Dudley, J. D. Veldhuis, and R. S. Swerdloff Comparative Pharmacokinetics of Three Doses of Percutaneous Dihydrotestosterone Gel in Healthy Elderly Men-A Clinical Research Center Study J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2749 - 2757. [Abstract] [Full Text]

				V. D. H. Ding, D. E. Moller, W. P. Feeney, V. Didolkar, A. M. Nakhla, L. Rhodes, W. Rosner, and R. G. Smith Sex Hormone-Binding Globulin Mediates Prostate Androgen Receptor Action via a Novel Signaling Pathway Endocrinology, January 1, 1998; 139(1): 213 - 218. [Abstract] [Full Text] [PDF]

				G. V. Avvakumov, Y. A. Muller, and G. L. Hammond Steroid-binding Specificity of Human Sex Hormone-binding Globulin Is Influenced by Occupancy of a Zinc-binding Site J. Biol. Chem., August 18, 2000; 275(34): 25920 - 25925. [Abstract] [Full Text] [PDF]